Merck & Co Inc
NYSE: MRK
$101.19
+$2.01 (+2.0%)
Closing Price on November 25, 2024
MRK Articles
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published:
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
Published:
ThinkstockOctober 22, 2015: Markets opened higher on Thursday on a better-than-expected report on new claims for unemployment benefits, but the better news for investors is that European Central Bank...
Published:
Last Updated:
ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities markets. In Europe prospects for further central bank easing...
Published:
Last Updated:
ThinkstockOctober 16, 2015: Markets opened higher on Friday following an expected drop of 0.2% in U.S. industrial production and a surprise jump of 2.5 points in the consumer sentiment index. Crude...
Published:
Last Updated:
thinkstockOctober 13, 2015: Markets opened lower on Tuesday following disappointing economic data from China and a lack of any U.S. data, good or bad. All sectors traded in the red with about an hour...
Published:
Last Updated:
The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
thinkstockOctober 7, 2015: Markets opened higher on Wednesday tagging along on a rise in European equities. The upbeat start gave way to a loss of enthusiasm following the release of U.S. crude oil...
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
Published:
Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now. With the fourth quarter just starting, many are more than relieved to put the third...
Published:
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Published:
One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given a golden opportunity to buy the top companies at much better prices.
Published: